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Background: Direct Vagus Nerve Stimulation (VNS) has shown promising results as a heart failure (HF) therapy. Amplitudes used clinically for VNS 
typically result in laryngeal vibration (LVib). We conducted an acute study to evaluate the cardiac and systemic effects of VNS in the internal jugular 
vein (IJV) at amplitudes that produce LVib.
Methods: Thirty subjects indicated for an electrophysiology study were enrolled. A decapolar catheter was placed in the IJV. VNS (20Hz, 500μs) was 
delivered at various locations and amplitudes (1.9±1.6mA) for 15-20s. Catheters were placed in the right atrium and ventricle, and 12 lead ECG was 
collected. Medians of the first and last 5s of intervals during normal sinus rhythm (NSR) and VNS were compared. In a subset of patients (n=11), 
serum catecholamines were measured before and after 10 minutes of VNS and compared.
Results: There is a small but statistically significant reduction in heart rate in the first 5s of VNS compared to NSR (Table 1). There was no effect on 
cardiac intervals in the last 5s of VNS, suggesting this effect is transient. No significant change in catecholamines due to VNS were observed across 
all subjects. However, there was a decrease in venous norepinephrine during VNS in subjects with HF (n=4) (-75±74 pg/mL) that was significantly 
different than the response in non-HF subjects (N=7) (9±51 pg/mL, p=0.035).
Conclusions: We conclude that transvenous low amplitude VNS effects efferent cardiac fibers and exerts systemic neurohormonal effects in heart 
failure.
